Trends · Daily since 18:00
Signal, by category.
Pivot the desk by domain — clinical AI, longevity, neurotech, policy, Portugal. Grouped by day, with the 18:00 daily read at the top of each.
ShowHide briefing index
Observador Tech
EU AI Act Tightens Safety Standards, Impacts Health Tech in Portugal
"While the Act aims for safety, its broad 'high-risk' classification for health AI may stifle innovation in smaller Portuguese startups by increasing compliance costs and delaying market entry, despite the clear need for regulatory oversight in clinical applications."
Read source →
Sifted
EU Seeks Bids for €10bn AI 'Gigafactory' Scheme
"While the capital infusion is significant, the actual impact on health AI will depend on whether this 'gigafactory' scheme can translate raw computing power into clinically validated applications and secure critical data pipelines, rather than just supporting general-purpose models."
Read source →
ShowHide briefing index
- 1.Grove AI acquired by Hippocratic AI to bolster clinical trial recruitment with voice agents
- 2.Hims & Hers Faces FTC Suit Over Data Privacy and Billing Practices
- 3.General Catalyst invests $450M in Function Health's preventative diagnostics
- 4.Slovenia's GenePlanet Secures Strategic Investment from Lauxera Capital Partners for Genomics Platform
MedCity News
Grove AI acquired by Hippocratic AI to bolster clinical trial recruitment with voice agents
"While the acquisition by Hippocratic AI points to growing interest in AI-driven trial recruitment, the two-year, post-founding acquisition window for Grove AI means its voice agent technology likely lacks extensive real-world, large-N clinical validation."
Read source →
MedCity News
Hims & Hers Faces FTC Suit Over Data Privacy and Billing Practices
"The core issue is Hims & Hers' data handling practices, specifically whether granular consumer health data was shared without explicit, informed consent, which could trigger significant GDPR-like enforcement within the US states leading this action, setting a precedent for digital health platforms."
Read source →
MedCity News
General Catalyst invests $450M in Function Health's preventative diagnostics
"The substantial capital infusion into Function Health validates the unit economics of a direct-to-consumer preventative diagnostics model, bypassing traditional gatekeepers but raising questions on clinical utility without integrated care pathways."
Read source →
EU-Startups
Slovenia's GenePlanet Secures Strategic Investment from Lauxera Capital Partners for Genomics Platform
"While the 'unicorn' claim is speculative, Lauxera's investment validates GenePlanet's B2B genomics and NGS platform, likely accelerating its international scale and data-driven diagnostic offerings, provided the unit economics of genetic testing can support rapid expansion."
Read source →
Adjacent
The people building all this show up in Lisbon & Porto — see the programme or reserve a seat.